67 results
DEFA14A
ADVM
Adverum Biotechnologies Inc
11 Jun 24
Additional proxy soliciting materials
4:19pm
.
Appointment of Director
Effective June 10, 2024, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, appointed
8-K
ADVM
Adverum Biotechnologies Inc
11 Jun 24
Departure of Directors or Certain Officers
4:16pm
Nominating and Corporate Governance Committee, appointed Szilárd Kiss, M.D. as a director to fill the vacancy on the Board created by Dr. Ozden’s
DEFA14A
ADVM
Adverum Biotechnologies Inc
28 May 24
Additional proxy soliciting materials
2:00pm
and Corporate Governance Committee
Chair
Member (Non- Chair)
Research and Development Committee
Chair/Co-Chair
Member (Non- Chair/Co-Chair)
The chair
8-K
EX-99.1
my5 gtimr
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-99.2
13ygmya xv
6 Feb 24
In the Court of Chancery of the State of Delaware
4:47pm
8-K
EX-10.1
v6ykb5j012lyj086
5 Feb 24
Entry into a Material Definitive Agreement
5:03pm
8-K/A
xzc7nqr 5x
4 Dec 23
Departure of Directors or Certain Officers
4:09pm
8-K
q30yfhae
6 Nov 23
Departure of Directors or Certain Officers
4:10pm
8-K
kr3zg5ls20tug7qx5
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
EX-1.1
dfrpvvn62dokn
11 May 23
Other Events
4:45pm
PRE 14A
btejf0o
14 Apr 23
Preliminary proxy
6:03am
8-K
yqil8llo7j5qdb0haui
17 Mar 22
Departure of Directors or Certain Officers
4:36pm